/Investor DB

Pappas Capital — 2020 Investments

4 investments dated 2020 · listed companies and verified rows first · show all

Amplyxamplyx.comMay 2020

Developing a new class of antifungal medicine to overcome limitations of current therapies.

Co-investorsBioBritGolden SeedsKeiretsu ForumPappas CapitalRiverVest Venture PartnersSofinnova Ventures+4 more

BioAtlabioatla.cominJul 2020 · $72.5M

BioAtla develops novel monoclonal antibody and cell-based therapeutics for cancer treatment using proprietary platforms including Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!).

BiotechHealthtechMedical DevicesSan Diego, US

Jay M. Short(Executive Officer, Director)Richard A. Waldron(Executive Officer)inCarolyn Short(Director)

Co-investorsKeshif VenturesPappas CapitalPfizer Venture InvestmentsHBM Healthcare InvestmentsPfizer VenturesSoleus Capital

Reneoreneo.deinDec 2020 · $95M

Reneo is an asset and investment management platform for decarbonizing residential real estate portfolios in Germany.

Climate TechEnterprise SoftwarePropTechGermany, DE

Lennart Börner(Founder & Co-CEO)inAlexander Graubner-Müller(Founder & Co-CEO)in

Co-investorsFoundamentalAbingworthAisling CapitalAmzak HealthEurazeoLakestar+4 more

Reneo Pharmaceuticalsreneopharma.comDec 2020 · $95M

Xoilac TV is a free online football (soccer) live-streaming platform serving fans in Vietnam, offering Full HD match broadcasts of European, Asian, Vietnamese, and international competitions.

ConsumerMedia & EntertainmentSports Tech

Co-investorsAisling CapitalChiesi VenturesNew Enterprise Associates (NEA)Pappas CapitalRiverVest Venture PartnersAbingworth+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.